PE/Cyanine7 anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_PECy7_090507
C57BL/6 mouse splenocytes stained with 30-F11 PE/Cyanine7
  • 30-F11_PECy7_090507
    C57BL/6 mouse splenocytes stained with 30-F11 PE/Cyanine7
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
103113 25 µg £60
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103114 100 µg £130
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Rodriguez de la Fuente L, et al. 2021. STAR Protoc. 2:100841. PubMed
  2. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  3. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
  4. Yang AC, et al. 2020. Nature. 583:425. PubMed
  5. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  6. Khare A, et al. 2016. Cell Rep. 15: 1700-1714. PubMed
  7. Bussières-Marmen S, et al. 2017. Cell Mol Immunol. 10.1038/cmi.2016.72. PubMed
  8. Tran NT, et al. 2019. Cell Rep. 28:3510. PubMed
  9. Garber C, et al. 2019. Nat Neurosci. 1.802777778. PubMed
  10. Dobie R, et al. 2020. Cell Reports. 29(7):1832-1847.e8.. PubMed
  11. Wu JH, et al. 2020. EMBO Mol Med. 12:e10154. PubMed
  12. Kim SS, et al. 2022. Cancers (Basel). 14:. PubMed
  13. García-Prat L, et al. 2020. Nat Cell Biol. 22:1307. PubMed
  14. Tatsuguchi T, et al. 2022. Int Immunol. 34:277. PubMed
  15. Pan J, et al. 2021. Mol Ther Nucleic Acids. 26:970. PubMed
  16. Helms EJ, et al. 2021. Cancer Discov. Online ahead of print. PubMed
  17. Huck NA, et al. 2021. J Neurosci. 41:4349. PubMed
  18. Wu Q, et al. 2021. Cancer Commun (Lond). Online ahead of prin. PubMed
  19. Ma Q, et al. 2021. Clin Transl Immunology. 10:e1300. PubMed
  20. Yagishita Y, et al. 2020. Cell Mol Gastroenterol Hepatol. . PubMed
  21. Wiesner DL, et al. 2020. Cell Host Microbe. 614:27. PubMed
  22. Wagner G, et al. 2017. Sci Rep. 7:40881. PubMed
  23. Weeden C, et al. 2017. PLoS Biol. 10.1371/journal.pbio.2000731. PubMed
  24. Hilliard K, et al. 2015. Infect Immun . 83: 4015 - 4027. PubMed
  25. Shi Y, et al. 2020. Med Sci Monit. 26:e923328. PubMed
  26. Smith NR, et al. 2017. Cell Mol Gastroenterol Hepatol. 0.395138889. PubMed
  27. Zhou J, et al. 2019. Immunity. 50:403. PubMed
  28. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  29. Chang T, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006485. PubMed
  30. Kim YS, et al. 2021. Cell Death Dis. 12:307. PubMed
  31. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  32. Manivasagam S, et al. 2022. J Immunol. 208:1341. PubMed
  33. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  34. Vila Ellis L, et al. 2020. Dev Cell. 617:52. PubMed
  35. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  36. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  37. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  38. Mansouri N, et al. 2019. JCI Insight. 4:e128060. PubMed
  39. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  40. White MPJ, et al. 2020. Front Immunol. 11:1830. PubMed
  41. Saito S, et al. 2020. Nutrients. 12:. PubMed
  42. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  43. Han Y, et al. 2020. Nat Commun. 11:1776. PubMed
  44. Little DR, et al. 2021. Nat Commun. 12:2509. PubMed
  45. Bhopale VM, et al. 2021. J Appl Physiol (1985). 130:1604. PubMed
  46. Zheng L, et al. 2022. J Neuroinflammation. 19:128. PubMed
  47. Mathews J, et al. 2014. PLoS One. 9:97707. PubMed
  48. Britschgi A, et al. 2017. Nature. 541:541-545. PubMed
  49. Valds-Mora F, et al. 2021. Cell Reports. 35(2):108945. PubMed
  50. DellOrso S, et al. 2021. STAR Protocols. 2(2):100451. PubMed
  51. Wang B, et al. 2017. EBioMedicine. 10.1016/j.ebiom.2017.03.041. PubMed
  52. Kaczmarek–Hájek K, et al. 2018. Elife. 7:e36217. PubMed
  53. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  54. Ohigashi I, et al. 2020. Cell Reports. 29(9):2901-2916.e6.. PubMed
  55. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  56. Kobayashi H, et al. 2020. STAR Protoc. 1:100078. PubMed
  57. Campanario S, et al. 2021. Front Cell Dev Biol. 8:620409. PubMed
  58. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  59. Jiang YH, et al. 2020. J Mol Cell Cardiol. 138:115. PubMed
  60. Pan J, et al. 2020. J Neuroinflammation. 17:97. PubMed
  61. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  62. Garber C, et al. 2018. Nat Immunol. 19:151. PubMed
  63. Mizuochi C, et al. 2012. PLoS One. 7:e35763. PubMed
  64. Gigliotti J, et al. 2013. J Am Soc Nephrol. 24:1451. PubMed
  65. Wang B,et al. 2017. Cell Discov.. 10.1038/celldisc.2017.36. PubMed
  66. Solanas G, et al. 2017. Cell. 170:678. PubMed
  67. Dubey LK, et al. 2019. Cell Rep. 27:2442. PubMed
  68. Chen C, et al. 2019. Cell Rep. 29:4200. PubMed
  69. Galvão I, et al. 2018. Front Immunol. 9:142. PubMed
  70. Yang R, et al. 2022. Front Pharmacol. 13:774440. PubMed
  71. Fix DK, et al. 2021. Aging Cell. 20:e13448. PubMed
  72. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  73. Zhu L, et al. 2021. Stem Cell Res Ther. 12:408. PubMed
  74. Bahar Halpern K, et al. 2020. Nat Commun. 11:1936. PubMed
  75. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  76. Gu H, et al. 2018. Aging (Albany NY). 1.525694444. PubMed
  77. McGowan SE, et al. 2018. Am J Physiol Lung Cell Mol Physiol. 315:L102. PubMed
  78. Cheng HW, et al. 2019. Nat Commun. 10:1739. PubMed
  79. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  80. Huang CH, et al. 2020. Adv Ther (Weinh). 3:. PubMed
  81. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  82. Okamura T, et al. 2021. Front Immunol. 12:669629. PubMed
  83. Dang Y, et al. 2021. J Cancer. 12:7158. PubMed
  84. Basu A, et al. 2021. Cancer Immunol Res. Online ahead of print. PubMed
  85. Fennell LM, et al. 2020. EMBO J. 39:e103303. PubMed
  86. Allen S, et al. 2011. J Virol. 85:11448. PubMed
  87. Jaworska K, et al. 2015. J Immunol. 194:325. PubMed
  88. Furuya Y, et al. 2015. PLoS Pathog. 11: 1005180. PubMed
  89. Gomzikova MO, et al. 2020. Sci Rep. 10:10740. PubMed
  90. Cain MP, et al. 2020. Dis Model Mech. 13:00. PubMed
  91. Court AC, et al. 2020. EMBO Rep. 21:e48052. PubMed
  92. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  93. Onder L et al. 2017. Immunity. 47(1):80-92 . PubMed
  94. Halpern KB, et al. 2018. Nat Biotechnol. 36:962. PubMed
  95. Kimbrough D, et al. 2018. J Mol Cell Cardiol. 119:51. PubMed
  96. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  97. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  98. Wang W, et al. 2020. Immunity. 51(6):1102-1118.e7.. PubMed
  99. Ellegast JM, et al. 2022. Cancer Discov. 12:1760. PubMed
  100. Liu T, et al. 2022. Front Immunol. 13:901349. PubMed
  101. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  102. Manco R, et al. 2021. Nat Commun. 12:3074. PubMed
  103. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  104. Berg AL, et al. 2022. Cancers (Basel). 14:. PubMed
  105. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  106. McCoy S 2015. Am J Physiol Lung Cell Mol Physiol. 309: L463-L474. PubMed
  107. Yen Y, et al. 2008. J Virol. 82:12312. PubMed
  108. Uribesalgo I, et al. 2019. EMBO Mol Med. 11:e9266. PubMed
  109. Son NH, et al. 2018. J Clin Invest. 128:4329. PubMed
  110. Sela Y, et al. 2021. Elife. 10: . PubMed
  111. Ishii H, et al. 2012. Cell Death Dis. 9;3:e363. PubMed
  112. Wang F, et al. 2021. Cell. 184(2):422-440.e17. PubMed
  113. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  114. Kellish P, et al. 2019. J Clin Invest. 130:2279. PubMed
  115. Magri G et al. 2017. Immunity. 47(1):118-134 . PubMed
  116. Pascual G, et al. 2021. Nature. 599:485. PubMed
  117. Kolodziejczyk AA, et al. 2020. Nat Med. 26:1899. PubMed
  118. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  119. Chu X, et al. 2021. Front Cell Dev Biol. 9:671841. PubMed
  120. Shafiei-Jahani P, et al. 2021. Nat Commun. 12:2526. PubMed
  121. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  122. Sydney Lavoie et al. 2019. eLife. 8 pii: e39982. PubMed
  123. Merrell AJ, et al. 2021. Hepatology. 74:444. PubMed
  124. Jin L, et al. 2022. J Immunol Res. 2022:7222638. PubMed
  125. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  126. Evgin L, et al. 2022. Sci Transl Med. 14:eabn2231. PubMed
  127. Wu X, et al. 2016. Sci Rep. 6:18685. PubMed
  128. Hasegawa T, et al. 2020. Sci Rep. 10:13480. PubMed
  129. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  130. van Gastel N, et al. 2020. Cell Metabolism. 32(3):391-403.e6. PubMed
  131. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  132. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  133. Kobayashi H, et al. 2020. Cell Reports. 28(1):145-158.e9.. PubMed
  134. Shen DD, et al. 2022. Mol Cancer. 21:75. PubMed
  135. Zhu J, et al. 2021. Cancer Cell Int. 21:529. PubMed
  136. Yuan M, et al. 2022. Oxid Med Cell Longev. 2022:5479491. PubMed
  137. Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed
  138. Li J, et al. 2020. Development. :. PubMed
  139. Tang Z, et al. 2021. Stem Cell Res Ther. 12:397. PubMed
  140. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  141. Nenasheva T, et al. 2017. PLoS One. 12(6):e0178983. PubMed
  142. Mohammadpour H, et al. 2021. Cell Rep. 37:109883. PubMed
  143. Zhu S, et al. 2022. EBioMedicine. 80:104060. PubMed
  144. Sung PS, et al. 2022. JCI Insight. :. PubMed
  145. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  146. Magness S, et al. 2013. Am J Physiol Gastrointest Liver Physiol. 305:542. PubMed
  147. Wang W, et al. 2021. STAR Protocols. 2(3):100756. PubMed
  148. Li S, et al. 2019. Front Neurol. 1.036805556. PubMed
  149. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  150. Zhu K, et al. 2022. EMBO Rep. 23:e54499. PubMed
  151. Nian Z, et al. 2021. Clin Cancer Res. 27:6026. PubMed
  152. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  153. Hakim R, et al. 2021. J Neurosci. 41:8441. PubMed
  154. Ognjenovic NB, et al. 2020. Dev Cell. 55:544. PubMed
  155. Gu H, et al. 2021. Elife. 10:. PubMed
  156. Hendee K, et al. 2021. Aging (Albany NY). 13:7781. PubMed
  157. Issah Y, et al. 2021. Elife. 10:. PubMed
  158. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  159. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  160. Smith NR, et al. 2018. Cell Mol Gastroenterol Hepatol. 6:79. PubMed
  161. Kelley WJ, et al. 2022. JCI Insight. 7: . PubMed
  162. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
  163. Fan X, et al. 2020. Acta Physiol (Oxf). 230:e13475. PubMed
  164. Fang Y, et al. 2022. Development. 149:. PubMed
  165. Boyce M, et al. 2022. Cells. 11:. PubMed
  166. Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed
  167. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  168. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  169. Béchade C, et al. 2020. Glia. . PubMed
  170. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  171. Oh J, et al. 2021. Clin Cancer Res. 27:4781. PubMed
  172. Piirainen S, et al. 2021. Glia. 69:2459. PubMed
  173. Li Q, et al. 2022. J Biol Chem. :101753. PubMed
  174. Dong H, et al. 2022. Nat Metab. 4:90. PubMed
  175. Andreou T, et al. 2021. J Immunother Cancer. 9:. PubMed
  176. Rochford I, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 321:L686. PubMed
  177. Sheng J, et al. 2021. eLife. 10:00. PubMed
  178. Moreno M et al. 2014. The Journal of Neuroscience. 34(24):8175-85 . PubMed
  179. Nguyen HX et al. 2017. J Neurosci. 37(38):9269-9287 . PubMed
  180. Ishihara J, et al. 2018. Nat Commun. 9:2163. PubMed
  181. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  182. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  183. Hussein M, et al. 2015. PLoS One. 10: 0135218. PubMed
  184. Gigliotti J, et al. 2015. J Am Soc Nephrol. 26: 2470 - 2481. PubMed
  185. Serr I, et al. 2016. Nat Commun. 7:10991. PubMed
  186. Gerner-Mauro KN, et al. 2020. Proc Natl Acad Sci U S A. 117:12182. PubMed
  187. Kimmel JC, et al. 2021. Cell Reports. 35(4):109046. PubMed
  188. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  189. Ghosh S, et al. 2019. Commun Biol. 0.325. PubMed
  190. Chithanathan K, et al. 2022. Biology (Basel). 11:. PubMed
  191. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  192. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  193. Song X, et al. 2021. FEBS Open Bio. 11:2453. PubMed
  194. Ren X, et al. 2021. Cell Death Dis. 12:484. PubMed
  195. Wu H, et al. 2020. Cell. 180(1):107-121.e17.. PubMed
  196. Muri J, et al. 2020. Cell Reports. 30(13):4399-4417. PubMed
RRID
AB_312978 (BioLegend Cat. No. 103113)
AB_312979 (BioLegend Cat. No. 103114)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Go To Top Version: 2    Revision Date: 05/14/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account